4CPS-119 Effectiveness of capecitabine treatment in metastasic colorectal cancer in elderly patients

BACKGROUND: Age is the major risk factor for metastasic colorectal cancer (mCRC), with 70% of patients older than 70 years. Furthermore, elderly patients are not represented enough in cancer clinical trials, so there is a lack of information about these patients. PURPOSE: To analyse the effectivenes...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Hosp Pharm
Autori principali: Soler, JI García, Molina, OM García, García, FJ Gómez, Lozano, E González, Jiménez, MDM Ruiz, Sánchez, S Vicente, Carrasco, A Laorden, Gómez, A Ruiz, Nieto, MA de la Rubia
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Group 2018
Soggetti:
Section 4: Clinical pharmacy services
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535258/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.210
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi